Premium
Skin cancers in Italian lung transplant recipients: Incidence and risk factors analysis
Author(s) -
Vecchiato Marco,
Piaserico Stefano,
Biolo Giulia,
Frigo Anna Chiara,
Loy Monica,
Rea Federico,
Russo Irene,
Alaibac Mauro
Publication year - 2021
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.14749
Subject(s) - medicine , cumulative incidence , incidence (geometry) , basal cell carcinoma , skin cancer , phototype , transplantation , risk factor , lung transplantation , lung cancer , univariate analysis , proportional hazards model , oncology , surgery , cancer , multivariate analysis , dermatology , basal cell , physics , optics
Only a few studies reported the incidence and risk factors of skin cancers in lung transplant recipients. The aim of this study was to determine the cumulative incidence of skin cancers in a cohort of patients undergoing lung transplantation and to define predictors of their development. About 247 consecutive patients receiving lung transplantation at the Thoracic Surgery Unit of University Hospital of Padova between May 1995 and October 2016 were studied. Cumulative incidence of skin cancers was estimated considering death as a competing event. The effect of potential predictors was evaluated with univariate and multivariable Cox models for competing risks. About 37 (15.0%) patients developed skin tumors. The cumulative incidence of any skin cancer was 14.2% at 5 years, 21.4% at 10 years, and 24.3% at 15 years posttransplantation. Age at transplantation, male gender, phototype II, and voriconazole use were independent risk factors for development of squamous cell carcinoma. Only male gender and phototype II were independent risk factors for development of basal cell carcinoma. Since lung transplant recipients have a greater risk of developing skin cancers, the management of these patients needs a multidisciplinary approach, in which dermatologists and transplant physicians have a primary role.